2014-2026 Global Blood Products Industry Market Research Report, Segment by Player, Type, Application, Marketing Channel, and Region
SKU ID :Maia-14810462 | Published Date: 24-Dec-2019 | No. of pages: 136Description
The worldwide market for Blood Products is estimated to grow at a CAGR of roughly X.X% in the next 8 years, and will reach X.X million US$ in 2026, from X.X million US$ in 2019.
The report covers market size status and forecast, value chain analysis, market segmentation of Top countries in
Major Companies Covered
Shanghai Kehua Bio-Engineering(KHB)
Octapharma
CBOP
Jiangxi Boya Bio-Pharmaceutical
Baxter
Kedrion
China Biologic Products Inc
Sichuan Yuanda Shuyang Pharmaceutical
Hualan Biological Engineering Inc
Beijing Tiantan Biological Products
Shanghai Institute for Biological Products
Grifols
RAAS
Shanghai RAAS Blood Products
Shanxi Kangbao Biological Product
CSL
Hualan Bio
Zhenxing Biopharmaceutical and Chemical
BPL
Mitsubishi Tanabe
Major Types Covered
Red Blood Cells (RBCs)
Fresh Frozen Plasma (FFP)
Cryoprecipitate
Platelets
WBCs
Immune Globulins
Whole Blood
Autologous Red Blood Cells
Albumin and Plasma Protein Fraction
Clotting Factors and Cryoprecipitate
Major Applications Covered
Hospital
Blood Station
Other
Top Countries Data Covered in This Report
United States
Canada
Germany
UK
France
Italy
Spain
Russia
Netherlands
Turkey
Switzerland
Sweden
Poland
Belgium
China
Japan
South Korea
Australia
India
Taiwan
Indonesia
Thailand
Philippines
Malaysia
Brazil
Mexico
Argentina
Columbia
Chile
Saudi Arabia
UAE
Egypt
Nigeria
South Africa
…
2019
The report covers market size status and forecast, value chain analysis, market segmentation of Top countries in
Major Region
s, such as North America, Europe, Asia-Pacific, Latin America and Middle East & Africa, by type, application and marketing channel. In addition, the report focuses on the driving factors, restraints, opportunities and PEST analysis of major regions.Major Companies Covered
Shanghai Kehua Bio-Engineering(KHB)
Octapharma
CBOP
Jiangxi Boya Bio-Pharmaceutical
Baxter
Kedrion
China Biologic Products Inc
Sichuan Yuanda Shuyang Pharmaceutical
Hualan Biological Engineering Inc
Beijing Tiantan Biological Products
Shanghai Institute for Biological Products
Grifols
RAAS
Shanghai RAAS Blood Products
Shanxi Kangbao Biological Product
CSL
Hualan Bio
Zhenxing Biopharmaceutical and Chemical
BPL
Mitsubishi Tanabe
Major Types Covered
Red Blood Cells (RBCs)
Fresh Frozen Plasma (FFP)
Cryoprecipitate
Platelets
WBCs
Immune Globulins
Whole Blood
Autologous Red Blood Cells
Albumin and Plasma Protein Fraction
Clotting Factors and Cryoprecipitate
Major Applications Covered
Hospital
Blood Station
Other
Top Countries Data Covered in This Report
United States
Canada
Germany
UK
France
Italy
Spain
Russia
Netherlands
Turkey
Switzerland
Sweden
Poland
Belgium
China
Japan
South Korea
Australia
India
Taiwan
Indonesia
Thailand
Philippines
Malaysia
Brazil
Mexico
Argentina
Columbia
Chile
Saudi Arabia
UAE
Egypt
Nigeria
South Africa
…
Years considered for this report:
Historical Years:
2014-2018Base Year:
2019Estimated Year:
2019Forecast Period:
2019-2026TOC
Tables & Figures
Companies
- PRICE
-
$3460$5000Buy Now